About the Authors
- Lena Backlund
-
* E-mail: lena.backlund@sll.se
Affiliation Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Catharina Lavebratt
-
Affiliations Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
- Louise Frisén
-
Affiliations Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden, Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
- Pernilla Nikamo
-
Current address: Dermatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
Affiliations Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
- Dzana Hukic Sudic
-
Affiliations Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
- Lil Träskman-Bendz
-
Affiliation Department of Clinical Sciences, University Hospital, Lund, Sweden
- Mikael Landén
-
Affiliations Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden, Institution of Neuroscience and Physiology, The Sahlgrenska Academy at Gothenburg University, Sweden
- Gunnar Edman
-
Affiliations Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden, Department of Psychiatry, Tiohundra AB, Norrtälje, Sweden
- Marquis P. Vawter
-
Affiliation Functional Genomics Laboratory, Department of Psychiatry and Human Behavior, School of Medicine, University of California Irvine, Irvine, California, United States of America
- Urban Ösby
-
Affiliations Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden, Department of Psychiatry, Tiohundra AB, Norrtälje, Sweden
- Martin Schalling
-
Affiliations Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
Competing Interests
The authors have read the journal's policy and have the following conflicts: LB has received consultancy fees from Bristol-Myers Squibb and has been reimbursed by Eli Lilly and Bristol-Myers Squibb for attending conferences and presenting lectures. UÖ has received grant/research support from Bristol-Myers Squibb and Janssen-Cilag and has been a consultant for or received fees for speaking and attending conferences from AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Pfizer. GE has been a consultant for AstraZeneca and Janssen-Cilag and his wife is a shareholder of AstraZeneca. ML has been reimbursed by Eli Lilly, AstraZeneca and Wyeth for lectures, serves on advisory boards for AstraZeneca and Lundbeck, and has received research grants from AstraZeneca. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: LB CL LF PN UÖ MPV MS. Performed the experiments: CL PN MPV DSH. Analyzed the data: LB CL PN DSH GE MPV. Contributed reagents/materials/analysis tools: LB LF UÖ LTB ML MPV MV MS. Wrote the paper: LB CL PN LTB ML MS UÖ GE MPV DZH MS.